相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of paediatric medicinal cannabis use: A scoping review
Colleen Pawliuk et al.
PAEDIATRICS & CHILD HEALTH (2021)
Symptoms, adverse events, and outcomes in the use of medicinal cannabis in children and adolescents with autism spectrum disorder: a scoping review protocol
Sarah Fletcher et al.
JBI EVIDENCE SYNTHESIS (2021)
Efficacy and safety of paediatric medicinal cannabis use: A scoping review
Colleen Pawliuk et al.
PAEDIATRICS & CHILD HEALTH (2021)
Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2016
Matthew J. Maenner et al.
MMWR SURVEILLANCE SUMMARIES (2020)
What are we targeting when we treat autism spectrum disorder? A systematic review of 406 clinical trials
Umberto Provenzani et al.
AUTISM (2020)
Effects of CBD-Enriched Cannabis sativa Extract on Autism Spectrum Disorder Symptoms: An Observational Study of 18 Participants Undergoing Compassionate Use
Paulo Fleury-Teixeira et al.
FRONTIERS IN NEUROLOGY (2019)
Cannabis-based products for pediatric epilepsy: A systematic review
Jesse Elliott et al.
EPILEPSIA (2019)
Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy
Lihi Bar-Lev Schleider et al.
SCIENTIFIC REPORTS (2019)
Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities
Dana Barchel et al.
FRONTIERS IN PHARMACOLOGY (2019)
Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems-A Retrospective Feasibility Study
Adi Aran et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2019)
Plasma anandamide concentrations are lower in children with autism spectrum disorder
Debra S. Karhson et al.
MOLECULAR AUTISM (2018)
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Andrea C. Tricco et al.
ANNALS OF INTERNAL MEDICINE (2018)
The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models
Erica Zamberletti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Oral cannabis extracts as a promising treatment for the core symptoms of autism spectrum disorder: Preliminary experience in Chilean patients
G. Kuester et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
Medical Cannabinoids in Children and Adolescents: A Systematic Review
Shane Shucheng Wong et al.
PEDIATRICS (2017)
Is the medical use of cannabis a therapeutic option for children?
Michael J. Rieder
PAEDIATRICS & CHILD HEALTH (2016)
Enhancement of Anandamide-Mediated Endocannabinoid Signaling Corrects Autism-Related Social Impairment
Don Wei et al.
CANNABIS AND CANNABINOID RESEARCH (2016)
Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy
Craig A. Press et al.
EPILEPSY & BEHAVIOR (2015)
Cannabinoids for Medical Use A Systematic Review and Meta-analysis
Penny F. Whiting et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Autism spectrum disorder: advances in evidence-based practice
Evdokia Anagnostou et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2014)
Alterations in the endocannabinoid system in the rat valproic acid model of autism
D. M. Kerr et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Cannabinoid Receptor Type 2, but not Type 1, is Up-Regulated in Peripheral Blood Mononuclear Cells of Children Affected by Autistic Disorders
Dario Siniscalco et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2013)
Consequences of Cannabinoid and Monoaminergic System Disruption in a Mouse Model of Autism Spectrum Disorders
E. S. Onaivi et al.
Current Neuropharmacology (2011)
Abstinent adolescent marijuana users show altered fMRI response during spatial working memory
Alecia D. Schweinsburg et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2008)
An open label study of the use of dronabinol (marinol) in the management of treatment-resistant self-injurious behavior in 10 retarded adolescent patients
Tarah Kruger et al.
JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS (2006)
分享论文
